SEC Tracker
Get the app

MaxCyte MXCT

Maxcyte, Inc.: Ownership stake disclosure

Ownership stake disclosure by Liontrust Investment Partners LLP

Form
Schedule 13D
Filed
Importance
Notable
  1. 5,081,403 shares held, 4.9235%
  2. Sells and buys shares between Aug 2026 and Oct 2026
  3. Trade prices range from $1.04 to $1.57

Written from the Schedule 13D on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when MaxCyte files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8731 and related industry codes: the same peer list as the financial tables.

  1. NRC Health NRC public float $195M, Jun 30, 2025
  2. Absci ABSI public float $304M, Jun 30, 2025
  3. OmniAb OABI public float $145M, Jun 30, 2025
  4. Neogenomics NEO public float $680M, Jun 30, 2025
  5. Inotiv NOTV public float $71M, Mar 31, 2025, over 18 months old